Advances in multidisciplinary treatment of small cell lung cancer
10.12354/j.issn.1000-8179.2024.20240691
- VernacularTitle:小细胞肺癌多学科治疗进展
- Author:
Li MENGJIE
1
;
Huang DINGZHI
Author Information
1. 天津医科大学肿瘤医院肺部肿瘤内科,国家恶性肿瘤临床医学研究中心,天津市恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室(天津市 300060)
- Keywords:
small cell lung cancer(SCLC);
multidisciplinary team(MDT);
surgery;
concurrent radiochemotherapy;
immunotherapy
- From:
Chinese Journal of Clinical Oncology
2024;51(16):822-828
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer(SCLC)is characterized by high malignancy and invasiveness.It is difficult to treat and has poor prognosis.The development of personalized and comprehensive treatment strategies through a multidisciplinary team(MDT)can effectively improve the survival and quality of life of patients with SCLC.Surgery is of great value in patients with early stage.Concurrent chemoradiotherapy is the cornerstone treatment for limited-stage SCLC,and immune consolidation can further improve the survival.Immunotherapy combined with chemotherapy has led to significant breakthroughs in the treatment of extensive-stage SCLC.With the advancement of radiotherapy technology and the development of antineoplastic agents,novel radiotherapy strategies and drug treatment schemes are being explored and optimized.Notably,several problems and challenges still remain.This article aimed to review the progress and strategies for the mul-tidisciplinary treatment of SCLC.
